Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Waltz, E. FDA launches priority vouchers for neglected-disease drugs. Nat Biotechnol 26, 1315–1316 (2008). https://doi.org/10.1038/nbt1208-1315
Issue Date:
DOI: https://doi.org/10.1038/nbt1208-1315
- Springer Nature America, Inc.
This article is cited by
-
Spanish group defeats Shkreli in Chagas voucher race
Nature Biotechnology (2017)
-
Combined insulin/GLP-1 pens near market
Nature Biotechnology (2016)
-
AbbVie buys last available priority voucher for $350 million
Nature Biotechnology (2015)